Diabetes UK   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: London United Kingdom (1934)

Organization Overview

First Clinical Trial
1997
NCT00327418
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Diabetes UK

Active Ingredients

Drugs in Phase 4 Trials (1)

atorvastatin (lipitor) (2 trials)

Drugs in Phase 3 Trials (1)

quinapril (accupril) (1 trial)

Drugs in Phase 2 Trials (1)

cannabis (1 trial)

Drugs in Other Trials (4)

acipimox (1 trial)

beetroot juice (1 trial)

liraglutide (victoza) (1 trial)

rutin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina, Unstable (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Diabetic Neuropathies (Phase 2)

Pain (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 7